期刊文献+

5-氟尿嘧啶控释植入剂在小鼠肿瘤组织的分布

Distribution of 5-fluorouracil controlled release implant in tumor bearing mice
下载PDF
导出
摘要 目的建立5-氟尿嘧啶(5-Fu)在小鼠肿瘤组织中的分析方法,并用于考察5-Fu控释植入剂在小鼠肿瘤组织的分布。方法荷瘤小鼠瘤周植入分别由PLGA 50/50和PLGA 75/25为载体制备的5-Fu控释植入剂,RP-HPLC测定小鼠肿瘤组织中的药物浓度。结果肿瘤组织中5-Fu的线性范围为0.5~15.4μg·g-1,准确度为97.5%~104.0%,提取回收率为81.9%~88.3%,日内RSD均<2.0%,日间RSD均<7.6%。以PLGA50/50、PLGA75/25为载体的5-Fu控释植入剂在荷瘤小鼠体内的药动学参数:tmax分别为9、15 d;Cmax分别为3.79、2.83μg·g-1;AUC分别为41.15、43.50(μg·g-1)×d。结论该分析方法可用于5-Fu在肿瘤组织中的分布行为研究,2种载体的5-Fu控释植入剂均能维持小鼠肿瘤组织中较长时间的药物分布,延长药效作用时间。 Objective To establish an assay of 5-fluorouracil(5-Fu) in tumor bearing mice,and to investigate the distribution of 5-Fu controlled release implant in the tumor.Methods The 5-Fu controlled release implant prepared by PLGA 50/50 and PLGA75/25 as carriers was inserted around the tumor.The concentrations of 5-Fu in the tumor were determined by RP-HPLC.Results The linearity of 5-Fu in the tumor was 0.5-15.4 μg·g-1.The accuracy and the extraction recovery were 97.5%-104.0% and 81.9%-88.3%.The intra-day and inter-day RSD were less than 2.0% and 7.6%,respectively.The tmax,Cmax and AUC for PLGA 50/50 implant were 9 d,3.79 μg·g-1and 41.15(μg·g-1)×d,respectively.The tmax,Cmax and AUC for PLGA 75/25 implant were 15 d,2.83 μg·g-1and 43.50(μg·g-1)×d,respectively.Conclusion The method is reliable in the study of distribution of 5-Fu in tumor bearing mice.The 5-Fu controlled release implant prepared with 2 kinds of polymers could extend the duration of drugs in the tumor.
出处 《中南药学》 CAS 2012年第9期641-643,共3页 Central South Pharmacy
基金 陕西省科技计划项目(编号:2011K12-03-04)
关键词 5-氟尿嘧啶 控释植入剂 高效液相色谱法 肿瘤组织分布 5-fluorouracil; controlled release implant; HPLC; tumor tissue distribution
  • 相关文献

参考文献12

  • 1Grem JL.5-Fluorouracil:forty-plus and still ticking.A review of itspreclinical and clinical development[J].Invest New Drugs,2000,18(4):299-313.
  • 2Sastre RL,Olmo R,Teijon C,et al.5-Fluorouracil plasma levelsand biodegradation of subcutaneously injected drug-loaded micros-pheres prepared by spray-drying poly(D,L-lactide)and poly(D,L-lactide-co-glycolide)polymers[J].Int J Pharm,2007,338(1-2):180-190.
  • 3Brem H,Ewend MG,Piantadosj S,et al.The safety of interstiti-al chemotherapy with BCNU-loaded polymer followed by radiationtherapy in the treatment of newly diagnosed malignant gliomas:phaseⅠtrial[J].J Neurooncol,1995,26(2):111-123.
  • 4LUB.New Techniques and New Dosage Froms of Drugs[M].Bei-jing:People’s Medicine Publishing House,1998:503-515.
  • 5张奇,邓英杰,罗国安.HPLC研究5-FU长循环脂质体大鼠体内药动学[J].中国药学杂志,2002,37(5):380.
  • 6师少军,徐戎,李忠芳,陈汇,陈华庭,曾繁典.氟尿嘧啶磁性微球在小鼠体内的药动学[J].中国医院药学杂志,2008,28(5):333-335. 被引量:3
  • 7洪艳艳,陈振东,张明军,俞敏,吴秀伟,叶瑞萍,刘利炜,杨扬.氟尿嘧啶植入剂治疗恶性胸腹水的药代动力学研究[J].中国临床药理学杂志,2009,25(4):298-301. 被引量:20
  • 8刘华顶,王世亮,俞敏,储成顶.氟尿嘧啶植入剂胃癌术后腹腔缓释化疗的药动学研究[J].癌症进展,2012,10(1):73-79. 被引量:13
  • 9Ren Y,Tianning C,Hualing C,et al.Microfabrication of bio-degradable(PLGA)honeycomb-structures and potential appli-cations in implantable drug delivery[J].Sensors and Actuators B(Chemical),2005,106(2):506-511.
  • 10Tabata Y,Ikada Y.Macrophage phagocytosis of biodegradable mi-crospheres composed of L-lactic acid/glycolic acid and copolymers[J].J Biomed Mater Res,1988,22:837-858.

二级参考文献18

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部